The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Corporate Authors:
      Bladder Cancer Study Group of Association of Urooncology, Turkey
    • Source:
      Publisher: Karger Country of Publication: Switzerland NLM ID: 0417373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0399 (Electronic) Linking ISSN: 00421138 NLM ISO Abbreviation: Urol Int Subsets: MEDLINE
    • Publication Information:
      Publication: Basel : Karger
      Original Publication: Basel.
    • Subject Terms:
      Nephroureterectomy* ; Ureteroscopy*; Carcinoma, Transitional Cell/*diagnosis ; Carcinoma, Transitional Cell/*surgery ; Kidney Neoplasms/*diagnosis ; Kidney Neoplasms/*surgery ; Ureteral Neoplasms/*diagnosis ; Ureteral Neoplasms/*surgery ; Urinary Bladder Neoplasms/*pathology; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies
    • Abstract:
      Objective: The objective of this study is to evaluate the effect of diagnostic ureterorenoscopy (URS) prior to radical nephroureterectomy (RNU) on intravesical recurrence (IVR), in patients with primary upper urinary tract urothelial carcinoma (UTUC).
      Materials and Methods: Retrospective analysis of 354 patients, who underwent RNU for UTUC from 10 urology centers between 2005 and 2019, was performed. The primary endpoint was the occurrence of IVR after RNU. Patients were divided into URS prior to RNU (Group 1) and no URS prior to RNU (Group 2). Rates of IVR after RNU were compared, and a Cox proportional hazards model was used to evaluate potential predictors of IVR.
      Results: After exclusion, a total of 194 patients were analyzed: Group 1 n = 95 (49.0%) and Group 2 n = 99 (51.0%). In Group 1, a tumor biopsy and histopathological confirmation during URS were performed in 58 (61.1%). The mean follow-up was 39.17 ± 39.3 (range 12-250) months. In 54 (27.8%) patients, IVR was recorded after RNU, and the median recurrence time within the bladder was 10.0 (3-144) months. IVR rate was 38.9% in Group 1 versus 17.2% in Group 2 (p = 0.001). In Group 1, IVR rate was 43.1% in those undergoing intraoperative biopsy versus 32.4% of patients without biopsy during diagnostic URS (p =0.29). Intravesical recurrence-free survival (IRFS) was longer in Group 2 compared to Group 1 (median IRFS was 111 vs. 60 months in Groups 2 and 1, respectively (p< 0.001)). Univariate analysis revealed that IRFS was significantly associated with URS prior to RNU (HR: 2.9, 95% CI 1.65-5.41; p < 0.001). In multivariate analysis, URS prior to RNU (HR: 3.5, 95% CI 1.74-7.16; p < 0.001) was found to be an independent prognostic factor for IRFS.
      Conclusion: Diagnostic URS was associated with the poor IRFS following RNU for primary UTUC. The decision for a diagnostic URS with or without tumor biopsy should be reserved for cases where this information might influence further treatment decisions.
      (© 2020 S. Karger AG, Basel.)
    • Contributed Indexing:
      Keywords: Diagnostic ureterorenoscopy; Intravesical recurrence; Radical nephroureterectomy; Upper urinary tract; Urothelial carcinoma
    • Publication Date:
      Date Created: 20201202 Date Completed: 20210722 Latest Revision: 20210722
    • Publication Date:
      20221213
    • Accession Number:
      10.1159/000511650
    • Accession Number:
      33264798